Limitations, agreements, and source contact

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma · Source last updated 2020-02-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

GT60

restrictive Agreement

true

point Of Contact

email

CANNDLClinicalScience@HCAHealthcare.com

organization

Sarah Cannon Development Innovations, LLC

phone

844-710-6157

title

Sarah Cannon

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice